Innvierte allocates in the month of September about 12 million euros to 2 new coinvestments in risk capital
These operations, carried out in innovative technology-based companies, are aimed at various developments in the Bio, Health and Agri-Food and ICT sectors.
The CDTI Innovation, promoter and sole shareholder of the company Innvierte, closed, last September, 2 co-investment operations, one of them strategic, amounting to 11,857,000 euros, in particular:
- ANACONDA BIOMED, S.L. (Barcelona) is a company dedicated to the design, development and marketing of advanced medical devices for thrombectomies. It is developing a pioneering system designed to improve both the efficacy and safety of mechanical thrombectomies in the treatment of acute ischemic stroke, one of the leading causes of mortality and disability in the world. The investment is made with YSIOS BIOFUND II INNVIERTE F.C.R., YSIOS BIOFUND II SIDE FUND F.C.R.E., SABADELL ASABYS HEALTH INNOVATION INVESTMENTS II, F.C.R., ASABYS TOP UP FUND F.C.R. e INNOGEST CÁPITAL II FUND and the contribution of the CDTI Innovation is 5,201,000 euros.
In addition, in the line of strategic companies, CDTI Innovation has committed 6.65 million euros in the company XOOPLE, S.L. (Madrid), the data infrastructure company that is building a global system for recording physical changes on Earth.
Innvierte
Innvierte is an initiative whose objective is to promote business innovation by supporting venture capital investment in technology-based or innovative companies. This program is implemented through the closed-ended collective investment company Innvierte Economía Permanente SICC S.M.E., S.A., self-managed and subject to the supervision of the National Securities Market Commission and of which CDTI Innovation is a single shareholder.
Innvierte is part of the Spanish Strategy of Science, Technology and Innovation 2021-2027, approved by Agreement of the Council of Ministers, in September 2020. This Strategy contains the objectives, reforms and measures that must be adopted throughout the field of R+D+I in order to boost its growth and impact, and is one of the pillars on which the design of the Government's R+D+I policy for the coming years is based.
CDTI Innovation
The Center for Technological Development and Innovation, CDTI E.P.E. It is the innovation agency of the Ministry of Science, Innovation and Universities, whose objective is the promotion of technological innovation in the business environment. The mission of the CDTI is to ensure that the Spanish business fabric generates and transforms scientific and technical knowledge into globally competitive, sustainable and inclusive growth.
You can check the conditions of the CDTI Innovation grants on the website: www.cdti.es.
More information:
Press Office
press@cdti.es
91-581.55.00
On the Internet
Website: www.cdti.es
On LinkedIn: https://www.linkedin.com/company/cdti/
In X: https://x.com/CDTI_innovacion
On YouTube: https://www.youtube.com/user/CDTIoficial
Website: https://www.innvierte.es/
This content is copyright © 2026 CDTI,EPE. The use and reproduction is allowed by citing the source and digital identity of CDTI (@CDTI_innovacion).